A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...

The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...

The FDA approval of Ervebo comes shortly after another Ebola vaccine developed by Johnson & Johnson and Bavarian Nordic, known as Ad26.ZEBOV/MVA-BN-Filo, was filed for approval in Europe.

The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...

Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

FDA Approves Merck’s Enflonsia to prevent RSV in infants. ... infants younger than 8 months who are entering their first RSV season if their mothers did not receive a maternal RSV vaccine.

The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to Truist Securities analysts. Meanwhile, the FDA moves forward on having ...

The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review ...

Verona Pharma’s flagship drug last year became the first new maintenance treatment for chronic obstructive pulmonary disease ...

BRAVECTO QUANTUM exemplifies Merck Animal Health’s commitment to groundbreaking science and has been recognized as a winner of the 2024 Edison Awards and the 2024 S&P Global Awards for Best New ...